Metastatic Colorectal Cancers Terminated Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01508000Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver MetastasesTreatment
NCT02654639Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal CancerTreatment
NCT00717990Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage TreatmentTreatment